Oorsprong van het eerstegraads netwerk van Gil Hakim
| Entiteit | Type entiteit | Industrie | |
|---|---|---|---|
| Public Company | Biotechnology | 21 |
Grafiek van bedrijven verbonden in de tweede graad
Connectie in verschillende bedrijven
Bedrijven verbonden met Gil Hakim via zijn persoonlijke netwerk
| Onderneming | Sector | Gelieerde personen | Hoofdpost |
|---|---|---|---|
| KITE PHARMA INC | Biotechnology | Chief Executive Officer Director of Finance/CFO Investor Relations Contact Director/Board Member Corporate Officer/Principal | |
| Yale University | College/University | Undergraduate Degree Corporate Officer/Principal Undergraduate Degree | |
VV Manager LLC
 VV Manager LLC Investment ManagersFinance VV Manager LLC (Vida Ventures) is a venture capital firm founded in 2017 by Arie Belldegrun, Arjun Goyal and Stefan Vitorovic. The firm is headquartered in Boston, Massachusetts. | Investment Managers | Founder Founder Consultant / Advisor | |
| TEVA PHARMACEUTICAL INDUSTRIES LIMITED | Pharmaceuticals: Generic | Director/Board Member General Counsel Director/Board Member | |
| The Hebrew University of Jerusalem | College/University | Undergraduate Degree Doctorate Degree | |
| Weizmann Institute of Science | College/University | Graduate Degree Doctorate Degree | |
| University of Cincinnati (Ohio) | College/University | Undergraduate Degree Undergraduate Degree | |
Sonablate Corp.
 Sonablate Corp. Medical SpecialtiesHealth Technology Sonablate Corp. develops and manufactures high intensity focused ultrasound surgical ablation systems. Its products include Sonablate 450, a HIFU solution that determines the safety and efficacy of a minimally invasive prostate cancer treatment; Sonablate 500, a HIFU surgical ablation system for the treatment of localized prostate cancer that delivers ablative therapy with the possibility of reducing side effects; and Sonatherm, a laparoscopic HIFU surgical ablation system that uses a laparoscopic probe to deliver robotic ablative therapy to soft tissue with a customizable ablation zone. The company was founded by Stephen R. Puckett Sr. and George M. Suarez in 2004 and is headquartered in Charlotte, NC. | Medical Specialties | Director/Board Member Chief Tech/Sci/R&D Officer | |
| UCLA Institute of Urologic Oncology | Director/Board Member Director/Board Member | ||
| ALLOGENE THERAPEUTICS, INC. | Biotechnology | Founder General Counsel | |
| David Geffen School of Medicine | College/University | Corporate Officer/Principal Corporate Officer/Principal | |
| JOHNSON & JOHNSON | Pharmaceuticals: Major | Corporate Officer/Principal Corporate Officer/Principal | |
| KRONOS BIO, INC. | Pharmaceuticals: Major | Founder Consultant / Advisor | |
| University of Wisconsin | College/University | Masters Business Admin Undergraduate Degree | |
cCAM Biotherapeutics Ltd.
 cCAM Biotherapeutics Ltd. Pharmaceuticals: MajorHealth Technology cCAM Biotherapeutics Ltd. is a preclinical-stage company engaging in the development of immunotherapies to treat cancer. The company was founded by Silvia Noiman and Gal Markel in 2010 and is headquartered in Hod Ha'Sharon, Israel. | Pharmaceuticals: Major | Director/Board Member Chairman | |
| University of California, Los Angeles | College/University | Undergraduate Degree Corporate Officer/Principal | |
BioSight Ltd.
 BioSight Ltd. Miscellaneous Commercial ServicesCommercial Services BioSight Ltd. is a clinical stage biotechnology company engaging in the development of therapeutics for hematological malignancies and disorders. The company was founded by Stela Gengrinovitchan and Mark Gengrinovitch on November 10, 1999 and is headquartered in Lod, Isreal. | Miscellaneous Commercial Services | Director/Board Member Chairman | |
Cell Design Labs, Inc.
 Cell Design Labs, Inc. BiotechnologyHealth Technology Cell Design Labs, Inc. develops disruptive cell-based therapies for cancer and other devastating diseases. The company was founded by Brian G. Atwood and Fred E. Cohen in 2016 and is headquartered in Emeryville, CA. | Biotechnology | Director/Board Member Founder | |
Kosan Biosciences, Inc.
 Kosan Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Kosan Biosciences, Inc. develops drugs for cancer therapeutics. The company was founded in 1995 and is headquartered in New York, NY. | Pharmaceuticals: Major | Director of Finance/CFO Corporate Officer/Principal | |
| University of Florida | College/University | Undergraduate Degree Doctorate Degree | |
Nutrinia Ltd.
 Nutrinia Ltd. Pharmaceuticals: MajorHealth Technology Nutrinia Ltd. develops bioactive feed supplements for infant formulas and animal feed. The firm is involved in broad intellectual property protection, industrial processes envelopment, conducting additional clinical trials and obtaining regulatory approval for the supplementation of pre-term and infant formulas with Insulin. The company was founded by Naim Shehadeh in 2003 and is headquartered in Ramat-Gan, Israel. | Pharmaceuticals: Major | Director/Board Member | |
CollPlant Ltd.
 CollPlant Ltd. BiotechnologyHealth Technology CollPlant Ltd. specializes in the development and commercialization of medical products. It develops and commercialize tissue repair products for orthobiologics and advanced wound care markets. The company was founded by Tsafrir Feigin Yehuda and Oded Shoseyov in 2004 and is headquartered in Ness Ziona, Israel. | Biotechnology | Director/Board Member | |
| COLLPLANT BIOTECHNOLOGIES LTD. | Medical Specialties | Director/Board Member | |
OCON Medical Ltd.
 OCON Medical Ltd. Medical/Nursing ServicesHealth Services OCON Medical Ltd. engages in the research and development of intrauterine device. Its products include Intrauterine Ball IUB and IUB SCu300. The company was founded by Ilan Baram on 2008 and is headquartered in Modiin, Israel. | Medical/Nursing Services | Chairman | |
Human Immunology Biosciences, Inc.
 Human Immunology Biosciences, Inc. BiotechnologyHealth Technology Human Immunology Biosciences, Inc. is a company based in South San Francisco, CA. Human Immunology Biosciences, Inc. was founded by Travis Murdoch, who has been the CEO since incorporation. | Biotechnology | Director/Board Member | |
| ERECH FINANCE CAHALACHA LTD | Medical Specialties | Director/Board Member | |
| Pontifax Management 2 G.P. (2007) Ltd. | Director/Board Member | ||
Eloxx Pharmaceuticals Ltd.
 Eloxx Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Eloxx Pharmaceuticals Ltd. provides biopharmaceutical research and development services. The firm specializes in the discovery, development, and commercialization of drug compounds for the treatment of genetic diseases. It focuses on the treatment of diseases caused by nonsense mutations, including Cystic fibrosis, Duchene Muscular Dystrophy, Usher syndrome, Ataxia-telangiectasia, Beta thalassemia, and Tay-Sachs Hurler syndrome. Its focus areas encompass clinical drug development and target drugs discovery programs. The company was founded by Silvia Noiman and Shmuel Tuvia in 2013 and is headquartered in Herzliya, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| Fusimab Ltd. | Director/Board Member | ||
| Spearhead, LLC | Chief Executive Officer | ||
BioMedix, Inc.
 BioMedix, Inc. Medical SpecialtiesHealth Technology BioMedix, Inc. provides equipment and services for non invasive detection of peripheral vascular disease. It provides suite of hardware, software and online services designed to cost-effectively detect peripheral arterial disease. The company was founded by Claver Bundac and Richard C. Magnuson in 1997 and is headquartered in St. Paul, MI. | Medical Specialties | Chief Executive Officer | |
| Pontifax Group | Founder | ||
Novotech Holdings Pty Ltd.
 Novotech Holdings Pty Ltd. Miscellaneous Commercial ServicesCommercial Services Novotech Health Holdings engages in the development of contract research organization platform. The company was founded on October 12, 2020 and is headquartered in Australia. | Miscellaneous Commercial Services | Director/Board Member | |
| PREVAIL THERAPEUTICS INC. | Biotechnology | Director/Board Member | |
| Pontifax Management 4 Gp 2015 Ltd. | Corporate Officer/Principal | ||
Roka Bioscience, Inc.
 Roka Bioscience, Inc. BiotechnologyHealth Technology Roka Bioscience, Inc. is a company that specializes in food safety technology. The company is based in Mendham, NJ and was founded in 2009 by Paul G. Thomas. Roka Bioscience's core technology is their pathogen detection assays which combine the power of target capture, transcription-mediated amplification, and hybridization protection assay to target ribosomal RNA (rRNA), an optimal target for molecular technology in food pathogen detection applications. The company offers a range of products including the Atlas® System and various detection assays for E. coli, Listeria, Salmonella, Campylobacter, and Legionella. Roka Bioscience also provides environmental testing solutions and technical support for their customers. Mary Duseau has been the CEO of the company since 2015. | Biotechnology | Director/Board Member | |
Pontifax (Israel) IV LP
 Pontifax (Israel) IV LP Financial ConglomeratesFinance Part of Pontifax Management Co. Ltd., Pontifax (Israel) IV LP is an investment services provider. The company is based in Hertsliya, Israel and was founded in 2015. | Financial Conglomerates | Director/Board Member | |
| Pontifax (Cayman) III LP | Investment Managers | Director/Board Member | |
| Pontifax (Israel) III LP | Investment Managers | Director/Board Member | |
| Spearhead Investments (Bio) Ltd. | Chairman | ||
Fore Biotherapeutics, Inc.
 Fore Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Fore Biotherapeutics, Inc. develops tumor specific driver mutations. It offers fully automated live-cell screening from NGS data. The company was founded by Haim Gil-Ad and Yoram Altschuler in 2011 and is headquartered in Philadelphia, PA. | Pharmaceuticals: Major | Director/Board Member | |
Lutris Pharma Ltd.
 Lutris Pharma Ltd. Pharmaceuticals: MajorHealth Technology Lutris Pharma Ltd. is working on the improvement of the anti-cancer therapy effectiveness and the quality of life for patients that are treated with Epidermal Growth Factor Receptor Inhibitors. The company was founded on December 14, 2015 and is headquartered in Tel Aviv, Israel. | Pharmaceuticals: Major | Director/Board Member | |
| KEROS THERAPEUTICS, INC. | Pharmaceuticals: Major | Director/Board Member | |
| ELOXX PHARMACEUTICALS, INC. | Biotechnology | Director/Board Member |
Statistieken
Internationaal
| Verenigde Staten | 27 |
| Israël | 24 |
| Australië | 2 |
Sectoraal
| Health Technology | 29 |
| Consumer Services | 9 |
| Finance | 5 |
| Commercial Services | 3 |
| Health Services | 2 |
Operationeel
| Director/Board Member | 186 |
| Corporate Officer/Principal | 65 |
| Independent Dir/Board Member | 50 |
| Chairman | 44 |
| Founder | 29 |
Sterkste connecties
| Insiders | |
|---|---|
| Fred Cohen | 58 |
| Arie Belldegrun | 42 |
| Ran Nussbaum | 38 |
| Kathryn Falberg | 30 |
| Chaim Hurvitz | 25 |
| Shawn Tomasello | 22 |
| Asher Holzer | 20 |
| Pini Orbach | 16 |
| Cynthia Butitta | 16 |
| Stuart Holden | 16 |
| Ronald Bentsur | 13 |
| Gary Titus | 13 |
| Elyse G. Seltzer | 11 |
| Christine Cassiano | 11 |
| James Ottinger | 10 |
